UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025192
Receipt number R000028980
Scientific Title Efficacy of contrast-enhanced endoscopic ultrasonography for diagnosing pancreatic tumor
Date of disclosure of the study information 2016/12/08
Last modified on 2016/12/08 23:00:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of contrast-enhanced endoscopic ultrasonography for diagnosing pancreatic tumor

Acronym

Efficacy of contrast-enhanced endoscopic ultrasonography for diagnosing pancreatic tumor

Scientific Title

Efficacy of contrast-enhanced endoscopic ultrasonography for diagnosing pancreatic tumor

Scientific Title:Acronym

Efficacy of contrast-enhanced endoscopic ultrasonography for diagnosing pancreatic tumor

Region

Japan


Condition

Condition

Pancreatic tumor

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The aims of this study are to assess benign and malignant difference in pancreatic tumor by using contrast-enhanced endoscopic ultrasonography and to assess the best differentiation method of benign and malignant lymph nodes by creating TIC(time intensity curve).
Finally,the aim of this study is to improve sensitivity,specificity,false negative rate by only using contrast-enhanced endoscopic ultrasonography.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Diagnostic ability for benign and malignant lymph nodes by using qualitative evaluation of contrast-enhanced endoscopic ultrasonography

Key secondary outcomes

To assess the usefulness of quantitative evaluation by using TIC analysis


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Contrast-enhanced endoscopic ultrasonography

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patient who indicate pancreatic tumor tract by imaging study
Patient who intend to endoscopic ultrasound-guided fine-needle aspiration for pancreatic tumor
Written informed consent
ECOG performance status = 0-2

Key exclusion criteria

Inapropriate to perform endoscopic ultrasonography
Blood coagulation disorder(PT-INR>1.5)or fewer platelets(<50,000mm3)
Patient who take anticoagulant or antiplatelet drug cannot stop these drugs
Allergy to iodine or eggs
Chances of pregnancy
Failure of other organs(ASA:Grade 3,4)
Inability to obtain informed consent

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takuji Iwashita

Organization

Gifu University Faculty of Medicine

Division name

Department of gastroenterology

Zip code


Address

1-1 Yanagido,Gifu,Gifu

TEL

058-230-6000

Email

takuji@w7.dion.ne.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takuji Iwashita

Organization

Gifu University Faculty of Medicine

Division name

Department of gastroenterology

Zip code


Address

1-1 Yanagido,Gifu,Gifu

TEL

058-230-6000

Homepage URL


Email

takuji@w7.dion.ne.jp


Sponsor or person

Institute

Gifu University Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

岐阜大学医学部附属病院(岐阜県)、岐阜市民病院(岐阜県)、岐阜県総合医療センター(岐阜県)


Other administrative information

Date of disclosure of the study information

2016 Year 12 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2016 Year 11 Month 01 Day

Date of IRB


Anticipated trial start date

2016 Year 12 Month 08 Day

Last follow-up date


Date of closure to data entry

2018 Year 12 Month 08 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 12 Month 08 Day

Last modified on

2016 Year 12 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028980


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name